You have 9 free searches left this month | to do more

evobrutinib

Evobrutinib is a drug used to treat Healthy, Relapsing-remitting Multiple Sclerosis, and Renal Impairment. Evobrutinib is being actively studied in 4 studies and prior, has been studied in 4.

Top SponsorsTop SitesTop Investigators
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNuvisan GmbH
EMD Serono Research & Development Institute, Inc.Please Contact U.S. Medical Information
Merck KGaA, Darmstadt, GermanyPlease Contact the Communication Center
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Recruiting
  • Healthy
  • Evobrutinib
  • +4 more
  • Neu-Ulm, Germany
    Nuvisan GmbH
2021-11-10
Nov 10, 2021
E
Terminated
  • Relapsing-remitting Multiple Sclerosis
  • Evobrutinib
  • +3 more
  • Rockland, Massachusetts
  • +1 more
2021-07-13
Jul 13, 2021
E
Terminated
  • Relapsing-remitting Multiple Sclerosis
  • Evobrutinib
  • +3 more
  • Rockland, Massachusetts
  • +1 more
2021-07-13
Jul 13, 2021
M
Completed
  • Healthy
  • Evobrutinib
  • Neu-Ulm, Germany
    Nuvisan GmbH
2020-07-03
Jul 3, 2020
M
Completed
  • Healthy
  • Evobrutinib
  • Groningen, Netherlands
    PRA Health Sciences
2020-07-03
Jul 3, 2020
M
Completed
  • Renal Impairment
  • Evobrutinib
  • Darmstadt, Germany
    Please Contact the Merck KGaA Communication Center
2019-05-15
May 15, 2019
E
Active, not recruiting
  • Relapsing-remitting Multiple Sclerosis
  • Evobrutinib
  • +2 more
  • Blagoevgrad, Bulgaria
  • +55 more
2021-05-04
May 4, 2021
M
Active, not recruiting
  • Relapsing Multiple Sclerosis
  • Evobrutinib
  • +3 more
  • Cullman, Alabama
  • +265 more
2021-10-11
Oct 11, 2021
M
Active, not recruiting
  • Relapsing Multiple Sclerosis
  • Evobrutinib
  • +3 more
  • Mobile, Alabama
  • +271 more
2021-10-11
Oct 11, 2021